Minoxidil Restores Thymic Growth in 22q11.2 Deletion Syndrome by Limiting Sox9+ Chondrocyte Expansion
July 2025
in “
Journal of Human Immunity
”
Studysummary This study found that administering minoxidil and PGE<sub>2</sub> to pregnant mice with 22q11.2 deletion syndrome models corrected multiple developmental anomalies, including thymus growth and parathyroid positioning, by targeting prenatal mesenchymal differentiation.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on rupress.org →